A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 17
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ML
Long Form : montelukast
No. Year Title Co-occurring Abbreviation
2019 Therapeutic and protective effects of montelukast against doxorubicin-induced acute kidney damage in rats. DOX, SOD, TBARS
2017 Renoprotective effects of montelukast in an experimental model of cisplatin nephrotoxicity in rats. CIS
2016 Anti-inflammatory Montelukast prevents toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Oxidative stress, histological alterations in liver, and serum cytokine levels. CAT, SOD, TCDD
2016 The beneficial effects of Montelukast against 2,3,7,8-tetrachlorodibenzo- p -dioxin toxicity in female reproductive system in rats. TCDD
2013 Radioprotective effect of montelukast sodium in rat lacrimal glands after radioiodine treatment. HG, RAI
2012 Beneficial effects of montelukast against methotrexate-induced liver toxicity: a biochemical and histological study. MDA, MPO, MTX
2012 Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats. ---
2011 Leukotriene D4 receptor antagonist montelukast alleviates protamine sulphate-induced changes in rat urinary bladder. GAG, MDA, PS, PS, RR
2010 Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction. AMP
10  2010 Dual inhibition of wound healing and oxidative process by montelukast in experimental colon anastomoses. bFGF, GPx, MDA, OAML, SOD, VEGF
11  2008 Leukotriene D4 receptor antagonist montelukast alleviates water avoidance stress-induced degeneration of the gastrointestinal mucosa. WAS
12  2004 Effect of montelukast and fluticasone propionate on airway mucosal blood flow in asthma. FP
13  2004 Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma. CIC, dd, FP, HFA, PL, SM
14  2004 Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis. AMP, AUC, FEX, PL, PNIF
15  2004 Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma. AIA, CysLT, PL, PNIF, VAS
16  2004 Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients. AMP, FEX, ICSs, PL
17  2002 A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis. FEX, LT, PIF, PL, SAR